About Monte Rosa Therapeutics, Inc. 
Monte Rosa Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 41 Schemes (27.81%)
Foreign Institutions
Held by 59 Foreign Institutions (5.51%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
3 Million
(Quarterly Results - Dec 2025)
Net Profit:
-46 Million
Pharmaceuticals & Biotechnology
USD 1,247 Million (Small Cap)
60.00
NA
0.00%
-1.57
8.52%
5.07






